CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer

Lung cancer (LC) is the most common cause of cancer-related death worldwide. Patients with LC are usually diagnosed at advanced phases. Five-year survival rate in LC patients is approximately 16%. Despite decades of research on LC treatments, clinical outcomes are still very poor, necessitating to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbari Kordkheyli, Vahid, Rashidi, Mohsen, Shokri, Yasaman, Fallahpour, Samane, Variji, Atena, Nabipour Ghara, Ehsan, Hosseini, Sayed Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106967/
https://www.ncbi.nlm.nih.gov/pubmed/35620343
http://dx.doi.org/10.34172/apb.2022.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106967/
https://www.ncbi.nlm.nih.gov/pubmed/35620343
http://dx.doi.org/10.34172/apb.2022.027

Ejemplares similares